SLP simulations-plus.com Market Cap to Net Assets Ratio

Simulations Plus, Inc. (SLP) - corporate logo

Simulations Plus, Inc. (SLP) owns a cloud IT environment for biomodeling that is deeply integrated into laboratory research cycles, creating high user dependency. This daily price action reflects a market dynamic fixed at 2.68. The business dominates the clinical trial simulation segment, which allows it to exercise significant pricing power. The GastroPlus software suite is recognized as the gold standard for regulators, ensuring one hundred percent customer retention.

SLP Simulations Plus, Inc.: Market Value to Book Value in the range 07/04/2022 - 10/18/2026
Brand item of Simulations Plus Inc

This indicator determines the strategic control premium by comparing the current market value of Simulations Plus, Inc. (SLP) with its net asset value. By analyzing the trend of the market-to-book ratio, an investor can see how the market values the modeling precision of Simulations Plus, Inc. (SLP) relative to capital expenditures amid the expansion of AI startups, which allows for an assessment of the asset's margin of safety.

Competitor analysis

Veeva Systems Inc. - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value doximity.com|HealthEquity (HQY) - Market Cap to Net Assets Ratio|Market Cap to Book Value Multiple Waystar Health (WAY)|CorVel Healthcare (CRVL) - Market Cap to Net Assets Ratio|Market Value to Book Value PRVA (Privia Medical Group)|Huron Consulting Group - Market Value to Book Value Ratio|Market Cap to Net Assets Ratio certara.com CERT|OMCL (Omnicell) - Market Capitalization to Book Value Ratio|GDRX - Market-to-Book Ratio|Market Capitalization to Book Value Ratio Schrödinger Inc.|PHR (Phreesia Health) - Capitalization to Book Value Ratio|OMDA: Market Value to Book Value Ratio|Market Capitalization to Book Value evolenthealth.com|HSTM (HealthStream) - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value DH (Definitive Healthcare Corp)|Consensus - Market Value to Book Value Ratio|AGL - Market Cap to Net Assets Ratio|Absci - Market Cap to Net Assets Ratio|SY: Market Capitalization to Book Value Ratio|NRC Health Inc. (NRC) - Market Value to Book Value Ratio|Spok Holdings Inc (SPOK) - Market Value to Book Value Ratio|OPRX (OptimizeRx Corp.) - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value Ratio TruBridge Corp (TBRG)|Market Cap to Net Assets Ratio SOPHiA GENETICS SA|Market Cap to Book Value Multiple healthcatalyst.com (HCAT)|Market Capitalization to Book Value Ratio CCLD|researchsolutions.com - Market Capitalization to Book Value|DLHC (DLH Holdings Corp) - Market Value to Book Value Ratio|ONMD: Market-to-Book Ratio|Market Value to Book Value Ratio Scienture Holdings Inc|HCTI (healthcaretriangle.com) - Capitalization to Book Value Ratio|ISPC: Market Value to Book Value Ratio|Market Capitalization to Book Value Bullfrog AI Holdings Inc (BFRG)|SCWorx Corporation (WORX) - Market Cap to Net Assets Ratio|Market Value to Book Value MSPR (MSP Recovery Corp)|iCoreConnect (ICCT) - Market Value to Book Value Ratio|trxadehealth.com - Market Capitalization to Net Assets|ORGS - Market Value to Book Value Ratio|R1 RCM Inc. (RCM) - Market Value to Book Value Ratio|SHCR: Market Cap to Net Assets Ratio|STRM (Streamline Health, Inc.) - Market Capitalization to Book Value Ratio|SYRA: Market Value to Book Value Ratio|Market Capitalization to Book Value ApolloMed (AMEH)|Model N (MODN) - Market Cap to Net Assets Ratio|Market Value to Book Value NextGen Healthcare Inc (NXGN)